Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; the prior government funding lapse notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about lapse in government funding and operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and a new footer revision 'v3.4.0'. Also adjusted capitalization and wording of related items (e.g., 'met QC Criteria' vs 'Met QC Criteria', 'data' vs 'Data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedVersion metadata updated from v3.3.3 to v3.3.4; no changes to study content or visible page details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing all participating states. Removed separate per-state location sections and the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no user-visible changes to the study details or page layout were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.